Spots Global Cancer Trial Database for Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies
Official Title: 3D Breast Ultrasound In Predicting Response to Breast Cancer Therapies
Study ID: NCT00721903
Conditions
Study Description
Brief Summary: The purpose of this study is to determine how well changes can be determined in malignant masses from ultrasound scans.
Detailed Description: To evaluate the proportions of correct diagnosis of response to breast Cancer therapies for localized breast cancer by ultrasound. To develop a model based on patient characteristics, physical exam, and radiologic studies which will predict the possibility that a patient has had a complete pathological response to chemotherapy neoadjuvant therapy.
Keywords
Eligibility
Minimum Age: 25 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Locations
University of Michigan Hospital, Ann Arbor, Michigan, United States
Contact Details
Name: Paul L. Carson, Ph.D.
Affiliation: University of Michigan
Role: PRINCIPAL_INVESTIGATOR
Name: Paul Carson, PhD
Affiliation: University of Michigan
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
